MCQOPTIONS
Saved Bookmarks
| 1. |
Which of the following has approved Itolizumab for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress syndrome? |
| A. | WHO India |
| B. | NITI Aayog |
| C. | AIIMS Delhi |
| D. | Drugs Controller General of India |
| E. | Indian Institute of Health Management Research. |
| Answer» E. Indian Institute of Health Management Research. | |